导致股价下跌的主要原因是公司宣布了重要的人事变动。联合健康集团任命Wayne S. DeVeydt为新任首席财务官，将于9月2日生效，接替自2016年以来一直担任该职位的John F. Rex。这一变动是公司持续领导层调整的一部分，也凸显了公司正在努力应对影响其业绩的运营挑战。新任CFO DeVeydt曾在Elevance Health（前身为Anthem）担任首席财务官，并有丰富的行业经验，但市场似乎对这一突然的人事变动反应谨慎。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.